{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:27:40Z","timestamp":1770834460118,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,11]]},"DOI":"10.1093\/eurheartj\/ehag036","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:45:15Z","timestamp":1768394715000},"page":"649-654","source":"Crossref","is-referenced-by-count":0,"title":["Focus on trials: atrial fibrillation, heart failure with reduced ejection fraction, acute coronary syndrome, ischaemic stroke, and renovascular hypertension"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Center of Excellence of Cardiovascular Sciences, Ospedale Isola Tiberina \u2013 Gemelli Isola , Rome ,","place":["Italy"]},{"name":"Catholic University of the Sacred Heart , Rome ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026021112584873200_ehag036-B1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/eurheartj\/ehaf1126","article-title":"The Year in Cardiovascular Medicine 2025: the top 10 papers in thrombosis and antithrombic therapy","volume":"47","author":"Andreotti","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/eurheartj\/ehaf1125","article-title":"The Year in Cardiovascular Medicine 2025: the top 10 papers in diabetes and metabolic disorders","volume":"47","author":"Cosentino","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B3","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1093\/eurheartj\/ehaf978","article-title":"Focus on the many facets of atrial fibrillation: from prediction to treatment","volume":"46","author":"Crea","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/eurheartj\/ehaf938","article-title":"Integrated care: a pathway to successful atrial fibrillation catheter ablation","volume":"47","author":"Schnabel","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B5","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1093\/eurheartj\/ehaf847","article-title":"Focus on trials: primary prevention, ischaemic heart disease, atrial fibrillation, and obstructive sleep apnoea","volume":"46","author":"Crea","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B6","doi-asserted-by":"publisher","first-page":"ehaf829","DOI":"10.1093\/eurheartj\/ehaf829","article-title":"Genetic evaluation of early-onset atrial fibrillation: impact on patient management","volume":"47","author":"Laws","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B7","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1093\/eurheartj\/ehaf582","article-title":"Not all atrial fibrillations are born equal: the impact of chronobiology","volume":"46","author":"Goette","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/eurheartj\/ehaf689","article-title":"Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial","volume":"47","author":"Vermeer","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B9","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1093\/eurheartj\/ehaf651","article-title":"Hypokalaemia in atrial fibrillation: a red flag for more comprehensive workup?","volume":"46","author":"Linz","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/eurheartj\/ehaf478","article-title":"Recent-onset atrial fibrillation: challenges and opportunities","volume":"47","author":"Svennberg","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/eurheartj\/ehaf655","article-title":"Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial","volume":"47","author":"Butler","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/eurheartj\/ehaf888","article-title":"Vericiguat in heart failure with reduced ejection fraction: being confident in the face of uncertainty","volume":"47","author":"Cannata","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/eurheartj\/ehaf673","article-title":"Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial","volume":"47","author":"Rossello","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/ehaf687","article-title":"Sex as a biological variable and pre-specified sub-subgroup analyses: what would Sir James Black and Sir Richard Peto say?","volume":"47","author":"Bairey Merz","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/eurheartj\/ehaf718","article-title":"Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?","volume":"47","author":"Galli","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B16","doi-asserted-by":"publisher","first-page":"ehaf745","DOI":"10.1093\/eurheartj\/ehaf745","article-title":"Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial","volume":"47","author":"Connors","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B17","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1093\/eurheartj\/ehaf642","article-title":"Estimating the long-term effects of aspirin for primary prevention","volume":"46","author":"Baigent","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B18","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1093\/eurheartj\/ehaf514","article-title":"Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial","volume":"46","author":"Wolfe","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B19","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/eurheartj\/ehaf127","article-title":"The Australian\u2013New Zealand SCAD observational cohort study: major adverse cardiovascular events are associated with ticagrelor combined with aspirin, FMD, and history of stroke","volume":"46","author":"Tweet","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B20","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1093\/eurheartj\/ehae773","article-title":"STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention","volume":"45","author":"Vergallo","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B21","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1093\/eurheartj\/ehae617","article-title":"Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial","volume":"45","author":"Watanabe","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehaf680","article-title":"Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial","volume":"47","author":"Dillinger","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/eurheartj\/ehaf956","article-title":"Twice-daily aspirin for acute coronary syndrome: one too many?","volume":"47","author":"McCarthy","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/eurheartj\/ehaf570","article-title":"Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial","volume":"47","author":"Guo","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/eurheartj\/ehaf610","article-title":"Remote ischaemic conditioning in stroke: turning a corner?","volume":"47","author":"B\u00f8tker","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/eurheartj\/ehaf702","article-title":"Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial","volume":"47","author":"Chen","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/eurheartj\/ehaf734","article-title":"Early management of mild ischaemic stroke: role of dual antiplatelet treatment","volume":"47","author":"Scheitz","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/eurheartj\/ehaf746","article-title":"Fractional flow reserve-guided renal artery stenting in atherosclerotic renovascular hypertension: the FAIR randomized trial","volume":"47","author":"Li","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/eurheartj\/ehaf729","article-title":"Improved patient selection for renal artery stenting: a game-changer","volume":"47","author":"White","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/eurheartj\/ehaf899","article-title":"The need for thrombus burden stratification in prosthetic valve thrombosis trials","volume":"47","author":"Sun","year":"2026","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B31","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1093\/eurheartj\/ehaf391","article-title":"Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial","volume":"46","author":"Karthikeyan","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021112584873200_ehag036-B32","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/eurheartj\/ehaf904","article-title":"Thrombus burden assessment by transoesophageal echocardiography and response to treatment","volume":"47","author":"Devasenapathy","year":"2026","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/6\/649\/66852427\/ehag036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/6\/649\/66852427\/ehag036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:58:52Z","timestamp":1770832732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/6\/649\/8472832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,2,11]]},"published-print":{"date-parts":[[2026,2,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag036","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,7]]},"published":{"date-parts":[[2026,2,7]]}}}